mefac 250 mg hard capsules
rowa pharmaceuticals limited - mefenamic acid - capsule, hard - 250 milligram(s) - fenamates; mefenamic acid
brupro max 400mg film-coated tablets
rowa pharmaceuticals limited - ibuprofen - film-coated tablet - 400 milligram(s) - propionic acid derivatives; ibuprofen - propionic acid derivatives - for the management of muscular pain, backache, dental pain and dysmenorrhoea
brupro rx 600mg film-coated tablets
rowa pharmaceuticals limited - ibuprofen - film-coated tablet - 600 milligram(s) - propionic acid derivatives; ibuprofen - propionic acid derivatives - it is indicated in the symptomatic management of various arthroses such as rheumatoid arthritis (including juvenile rheumatoid arthritis or still’s disease) and osteoarthritis, fibrositis, ankylosing spondylitis and other muscular syndromes, such as low back pain, soft tissue trauma and various inflammations of tendon, joint capsules and ligaments.
xtex 250 mg /5 ml oral solution
rowa pharmaceuticals limited - carbocisteine - oral solution - 250 mg/5ml - mucolytics; carbocisteine
tradol 50 mg effervescent tablets
rowa pharmaceuticals limited - tramadol hydrochloride - effervescent tablet - 50 milligram(s) - other opioids; tramadol
carbosan 2% w/w gel
rowa pharmaceuticals limited - carbenoxolone sodium - gel - 2 percent weight/weight - carbenoxolone
magnesium verla 5 mmol granules for oral solution
rowa pharmaceuticals limited - magnesium - granules for oral solution - 5 millimole(s) - magnesium aspartate
rowarolan cutaneous powder
rowa pharmaceuticals limited - calcium carbonate - cutaneous powder - percent volume/volume
tropex 5% w/v ear drops solution
rowa pharmaceuticals limited - phenazone - ear drops, solution - 5 percent weight/volume - analgesics and anesthetics; phenazone
razole 10 mg gastro-resistant tablets
rowa pharmaceuticals limited - rabeprazole sodium - gastro-resistant tablet - 10 milligram(s) - proton pump inhibitors; rabeprazole - alimentary tract and metabolism, drugs for peptic ulcer and gastro-oesophageal reflux disease (gord), proton pump inhibitors - it is indicated in: active duodenal ulcer; active benign gastric ulcer; symptomatic erosive or ulcerative gastro-oesophageal reflux disease (gord); gastro-oesophageal reflux disease, long-term management (gord maintenance); symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic gord) zollinger-ellison syndrome; in combination with appropriate antibacterial therapeutic regimens for the eradication of helicobacter pylori in patients with peptic ulcer disease